Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
Pharmaceutics · 01.10.2025 · 17 (10) · 1281
DOI: 10.3390/pharmaceutics17101281 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 01.10.2025. Verfasst von Lian Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, No. 639 Longmian A…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, China.
Abstract (Originalsprache)
In recent years, microneedles (MNs), an innovative transdermal drug delivery system, have demonstrated significant advantages in treating diverse skin diseases. The stratum corneum (SC), with its ‘brick-mortar’ structure, is the main barrier to drug penetration into the skin. MNs—including solid, coated, hollow, dissolving, and hydrogel-forming types—penetrate it minimally to form temporary micro-channels, enabling efficient delivery of a wide range of therapeutic agents. These include small molecules, biologics, nanoparticles, and photosensitizers, among others. This technology has been effectively applied in the treatment of androgenetic alopecia, acne, scars, melanoma, psoriasis, atopic dermatitis, and vitiligo. By avoiding stimulation of dermal blood vessels and nerves, MNs offer low pain and high patient compliance. These advantages underscore their broad clinical potential for dermatologic therapy. Future studies must optimize material selection, drug-carrying efficiency, and scale-up production to facilitate clinical translation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, No. 639 Longmian Avenue, Jiangning District, Nanjing 211198, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province, China
Zitieren
APA
Zhou, L., Xu, S., & Li, S. (2025). Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases. Pharmaceutics, 17(10), 1281. https://doi.org/10.3390/pharmaceutics17101281
Vancouver
Zhou L, Xu S, Li S. Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases. Pharmaceutics. 2025;17(10):1281. doi:10.3390/pharmaceutics17101281
BibTeX
@article{Zhou2025,
author = {Zhou, Lian and Xu, Shilong and Li, Siwen},
title = {Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {10},
pages = {1281},
doi = {10.3390/pharmaceutics17101281}
}
EUVIMED